Bharat Biotech's COVID-19 vaccine "Covaxin" enters phase-3 trials

Speaking virtually at a programme organised by the Indian School of Business, Ella said the company is also working on another vaccine for COVID-19 which would be in the form of nasal drops and can be ready by next year.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3kAQwbZ
via IFTTT

0 comments:

Post a Comment